CENTESSA PHARMACEUTICALS-ADR (CNTA) Stock Income Statement
USA - NASDAQ:CNTA - US1523091007 - ADR
27.85 USD
-0.15 (-0.54%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 15.00M | 0 | 6.85M | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 228.80M | 201.06M | 178.14M | 212.26M | 153.63M | |||
| Research and Development | 178.62M | 150.24M | 124.41M | 155.08M | 95.66M | |||
| Selling, General, and Administrative Expenses | 50.18M | 50.81M | 53.73M | 55.20M | 42.89M | |||
| Operating Income | -213.80M | -201.06M | -171.28M | -212.26M | -153.63M | |||
| Interest Income/Expense | 9.75M | 3.93M | 570.00K | -7.03M | -1.17M | |||
| Other Income/Expense | -1.16M | -1.69M | -5.43M | 2.34M | -5.70M | |||
| Non Recurring Items | null | -34.10M | null | 0 | -220.45M | |||
| Income Before Taxes | -239.31M | -232.91M | -176.14M | -216.95M | -380.96M | |||
| Income Tax | 3.39M | 2.84M | -25.06M | -750.00K | 110.00K | |||
| Net Income | -242.70M | -235.76M | -151.09M | -216.21M | -381.07M | |||
| EBITDA | -212.89M | -200.11M | -170.47M | -212.13M | -153.60M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.8206419573247015 | -2.0551450321239915 | -1.5675782136264036 | -2.3051153310057884 | -5.059279103116601 | |||
| Non GAAP EPS | -1.5699999999999998 | -1.73 | -1.57 | -2.31 | null | |||
| Statistics | ||||||||
| Profit Margin | -1617.99% | N/A | -2204.65% | N/A | N/A | |||
| Operating Profit Margin | -1425.33% | N/A | -2499.39% | N/A | N/A | |||
All data in USD